Clonidine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.1 mg, 0.2 mg, 0.3 mg
Reference Brands: Catapres(US)
Category:
Hypertension
Clonidine is an alpha-2 adrenergic agonist that decreases sympathetic nerve activity, leading to reduced blood pressure. It effectively treats hypertension, ADHD, and certain pain conditions. Benefits include rapid blood pressure control, decreased cardiovascular risk, improved symptom management, and supporting long-term cardiovascular health with convenience and fewer side effects.
Clonidine tablets is available in Tablets
and strengths such as 0.1 mg, 0.2 mg, 0.3 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clonidine tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clonidine tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clonidine tablets, marketed as Catapres or generic in the US and EU, are approved for hypertension, ADHD, and pain management. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and quality data, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability of clonidine tablets, helping healthcare providers effectively manage hypertension and related conditions worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing